Phillips-Medisize, a Molex company, has completed another expansion to the medical facility, adding capabilities in drug handling to serve its pharmaceutical customers with the complete manufacture of drug delivery devices and compliance to the FDA 21 CFR 210/211 requirements.
The New Richmond facility will add nearly 70,000 sq-ft of additional space this year, implementing automation, material handling, robotics and high-tech manufacturing to serve the diagnostics, drug delivery and medical device markets. The facility offers services in molding, assembly, labeling, packaging, kitting, serialization, sterilization management and bulk distribution.
“This is the second expansion of our New Richmond facility in less than three years. We are excited about the continued growth we are experiencing and the addition of drug handling capabilities we are able to offer our customers at another facility. The expanded drug handling capability will allow Phillips-Medisize to further consolidate the supply chain for our customers,” says Matt Jennings, President, Phillips-Medisize.
This expansion is a result of the continued business growth and acceleration for complete design, development and manufacturing of combination products, which has created a demand for more than 100 jobs in various departments, ranging from entry-level positions to roles in automation, engineering and management.
